enGene
Jake Tuleja is a finance professional with a background in financial operations and analysis. Currently serving as a Financial Operations Analyst at enGene since April 2025, Jake previously held the position of Financial Analyst at Cytiva from July 2023 to April 2025 and was a Finance Associate at Sumitomo Pharma America Holdings, Inc. from May 2022 to July 2023. Prior experience includes working as a Finance and Marketing Coordinator at Pragmatic Consulting, Inc. and as a Business Administration Intern at Alternate Power Source, Inc. Jake earned a Bachelor of Business Administration in Finance and Marketing from the University of New Hampshire, graduating in 2022.
This person is not in any teams
This person is not in any offices
enGene
enGene Inc. is a biotechnology company developing a proprietary non-viral gene therapy platform for localized delivery of nucleic acid payloads to mucosal tissues. The dually derived chitosan (DDX) platform has a high-degree of payload flexibility including DNA and various forms of RNA (siRNA, shRNA, lncRNA etc.) with broad tissue and disease applications